Home/Filings/4/0001209191-21-017955
4//SEC Filing

Ferayorni Justin John 4

Accession 0001209191-21-017955

CIK 0001008586other

Filed

Mar 3, 7:00 PM ET

Accepted

Mar 4, 5:54 PM ET

Size

8.4 KB

Accession

0001209191-21-017955

Insider Transaction Report

Form 4
Period: 2021-03-02
Transactions
  • Award

    Common Stock, $0.01 par value

    2021-03-02$1.60/sh+625,000$1,000,000625,000 total(indirect: Refer to footnote)
Holdings
  • Common Stock, $0.01 par value

    4,305,882
  • Common Stock, $0.01 par value

    105,181
Footnotes (4)
  • [F1]The reported securities represent 3,598,334 shares held directly by Tamarack Global Healthcare Fund, L.P. ("Fund 1") and 707,548 shares held directly by Tamarack Global Healthcare Fund QP, L.P. ("Fund 2"). Tamarack Capital Management, LLC is the general partner of Fund 1 and Fund 2, Tamarack Advisers, LP is the investment adviser to Fund 1 and Fund 2, and Justin J. Ferayorni is the sole managing member of both Tamarack Capital Management, LLC and Tamarack Capital GP, LLC. Tamarack Capital Management, LLC, Tamarack Advisers, LP, and Mr. Ferayorni may be deemed indirect beneficial owners of the shares held by Fund 1 and Fund 2 for purposes of Section 13(d) of the Securities Exchange Act of 1934 (the "Act").
  • [F2]Tamarack Capital Management, LLC, Tamarack Advisers, LP, and Mr. Ferayorni disclaim beneficial ownership of any of the shares held by Fund 1 and Fund 2 for the purpose of determining whether they are subject to Section 16 of the Act, however, in reliance on Rule 16a-1(a)(1)(v) and (vii) under the Act. To the extent that they might be deemed subject to Section 16, they disclaim beneficial ownership of securities held by the Fund 1 and Fund 2 for purposes of Rule 16a-1(a)(2), except to the extent of their pecuniary interest therein, if any.
  • [F3]The reported securities represent shares owned directly by Mr. Ferayorni.
  • [F4]The reported securities represent 625,000 shares held directly by Tamarack Global Healthcare Fund, L.P. ("Fund 1").Shares were issued pursuant to an underwritten public offering of Streamline Health Solutions, Inc. common stock, par value $0.01 per share. The price to the public in the offering was $1.60 per share of common stock.

Issuer

STREAMLINE HEALTH SOLUTIONS INC.

CIK 0001008586

Entity typeother

Related Parties

1
  • filerCIK 0001790497

Filing Metadata

Form type
4
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 5:54 PM ET
Size
8.4 KB